Mawson Infrastructure Group Inc. (NASDAQ:MIGI) has disclosed the upcoming departure of Mr. Craig Hibbard from his role as Chief Development Officer. The announcement came through a filing with the Securities and Exchange Commission dated August 7, 2024. Mr. Hibbard will continue his duties until February 6, 2025, to allow for a structured transition of his responsibilities.
The company, which operates under the industrial classification of Finance Services, stated that Mr. Hibbard's resignation was due to personal reasons and not due to any disagreements with the company's management or operational results. Following Mr. Hibbard's departure, the position of Chief Development Officer will not be filled. Instead, his responsibilities will be distributed among the remaining members of the management team.
Mawson Infrastructure Group, formerly known as Wize Pharma, Inc., and with previous names OphthaliX, Inc. and DENALI CONCRETE MANAGEMENT INC., is based in Midland, Pennsylvania. The company has emphasized that the transition is expected to be smooth and will not disrupt the company's operations.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.